Decoy Therapeutics Inc.
DCOYNasdaqCIK 1615219HealthcareFiscal year ends Dec 31
Reports and events: 272 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0720:59 ET | S-1 | Registration statement | 0001193125-26-417053 |
| 2026-09-2321:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001615219-26-000019 |
| 2026-09-1521:00 ET | 8-K | 5.07 Shareholder vote results | 0001615219-26-000016 |
| 2026-08-1220:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-346852 |
| 2026-08-0420:59 ET | DEF 14A | Proxy statementPeriod 2026-09-14 | 0001193125-26-332762 |
| 2026-07-1521:14 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-304949 |
| 2026-07-1020:26 ET | S-1 | Registration statement | 0001193125-26-300954 |
| 2026-06-2910:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-286737 |
| 2026-06-1522:54 ET | S-1 | Registration statement | 0001193125-26-269891 |
| 2026-06-0412:26 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001193125-26-256541 |
| 2026-05-1920:06 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001193125-26-230749 |
| 2026-05-0820:45 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-214816 |
| 2026-04-3017:03 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-195909 |
| 2026-04-0213:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-139145 |
| 2026-03-3121:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-134897 |
| 2026-03-0514:21 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-092748 |
| 2026-02-2514:15 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-068813 |
| 2026-01-0922:08 ET | DEF 14A | Proxy statementPeriod 2026-02-24 | 0001193125-26-008944 |
| 2026-01-0817:38 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-26-000013 |
| 2026-01-0222:14 ET | 8-K | 3.01 Delisting notice | 0001615219-26-000005 |
| 2026-01-0222:13 ET | 8-K | 5.07 Shareholder vote results | 0001615219-26-000003 |
| 2025-12-1921:31 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001615219-25-000197 |
| 2025-11-1921:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001615219-25-000168 |
| 2025-11-1722:23 ET | 8-K | 7.01 Regulation FD disclosure | 0001615219-25-000166 |
| 2025-11-1422:23 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001615219-25-000164 |
| 2025-11-1321:08 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000162 |
| 2025-11-0719:16 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001615219-25-000152 |
| 2025-10-2116:09 ET | S-1/A | Registration statement, amended | 0001628280-25-045619 |
| 2025-10-2115:57 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001615219-25-000148 |
| 2025-10-1412:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000145 |
| 2025-10-0620:12 ET | 8-K | 8.01 Other events | 0001615219-25-000142 |
| 2025-09-2321:27 ET | S-1/A | Registration statement, amended | 0001628280-25-042500 |
| 2025-09-1811:01 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001615219-25-000135 |
| 2025-09-0912:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000125 |
| 2025-08-2720:10 ET | 8-K | 8.01 Other events | 0001615219-25-000119 |
| 2025-08-2621:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000117 |
| 2025-08-2620:07 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001615219-25-000115 |
| 2025-08-2221:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-041043 |
| 2025-08-1812:33 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001615219-25-000107 |
| 2025-08-1515:03 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000101 |
| 2025-08-1221:27 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001615219-25-000096 |
| 2025-08-0800:50 ET | S-1/A | Registration statement, amended | 0001628280-25-039090 |
| 2025-07-3121:02 ET | 8-K | 2.02 Results of operations; 3.02 Unregistered sale of equity | 0001615219-25-000080 |
| 2025-07-3115:08 ET | S-1/A | Registration statement, amended | 0001628280-25-036892 |
| 2025-07-2920:54 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001615219-25-000078 |
| 2025-07-2821:05 ET | 8-K | 8.01 Other events | 0001615219-25-000076 |
| 2025-07-2112:39 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001615219-25-000072 |
| 2025-07-1412:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000069 |
| 2025-07-0816:00 ET | 8-K | 5.07 Shareholder vote results | 0001615219-25-000066 |
| 2025-06-1621:01 ET | S-1/A | Registration statement, amended | 0001628280-25-031631 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.